These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31862213)
1. PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy. Yeh HC; Margulis V; Singla N; Hernandez E; Panwar V; Woldu SL; Karam JA; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Li CC; Ke HL; Li WM; Lee HY; Rapoport LM; Lotan Y; Kapur P; Shariat SF; Hsieh JT; Wu WJ Urol Oncol; 2020 May; 38(5):496-505. PubMed ID: 31862213 [TBL] [Abstract][Full Text] [Related]
2. The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy. Abufaraj M; Kimura S; Haitel A; Iwata T; Isleem U; D'Andrea D; Soria F; Mori K; Rink M; Bensalah K; Rouprêt M; Margulis V; Briganti A; Karakiewicz PI; Shariat SF Urol Oncol; 2020 Aug; 38(8):685.e17-685.e25. PubMed ID: 32381392 [TBL] [Abstract][Full Text] [Related]
3. Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomy. Yeh HC; Li CC; Chien TM; Li CY; Cheng YC; Woldu SL; Robyak H; Huang CN; Ke HL; Li WM; Lee HY; Yeh BW; Yang SF; Tu HP; Sagalowsky AI; Raman JD; Singla N; Margulis V; Lotan Y; Hsieh JT; Wu WJ World J Urol; 2021 Feb; 39(2):491-500. PubMed ID: 32318857 [TBL] [Abstract][Full Text] [Related]
4. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage. Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630 [TBL] [Abstract][Full Text] [Related]
5. Concomitant carcinoma in situ as a prognostic factor in the upper tract urothelial carcinoma after radical nephroureterectomy: A systematic review and meta-analysis. Gao X; Ma Y; Chen G; Chen J; Li H; Li H; Wei X; Wang K Urol Oncol; 2020 Jun; 38(6):574-581. PubMed ID: 32273049 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy. Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449 [TBL] [Abstract][Full Text] [Related]
7. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma. Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890 [TBL] [Abstract][Full Text] [Related]
8. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma. Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823 [TBL] [Abstract][Full Text] [Related]
9. Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy. Mori K; Janisch F; Mostafaei H; Kimura S; Lysenko I; Karakiewicz PI; Briganti A; Enikeev DV; Rouprêt M; Margulis V; Chlosta P; Nyirady P; Babjuk M; Egawa S; Shariat SF Urol Oncol; 2020 Jun; 38(6):601.e17-601.e24. PubMed ID: 32127252 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration. Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197 [TBL] [Abstract][Full Text] [Related]
11. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma. Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis. Mori K; Janisch F; Mostafaei H; Lysenko I; Kimura S; Egawa S; Shariat SF Urol Oncol; 2020 May; 38(5):315-333. PubMed ID: 32088103 [TBL] [Abstract][Full Text] [Related]
14. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A. Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102 [TBL] [Abstract][Full Text] [Related]
15. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma. Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management. Pelcovits A; Mueller-Leonhard C; Mega A; Amin A; Kim SP; Golijanin D; Gershman B World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818 [TBL] [Abstract][Full Text] [Related]
17. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372 [TBL] [Abstract][Full Text] [Related]
18. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. Ehdaie B; Furberg H; Zabor EC; Ostroff JS; Shariat SF; Bochner BH; Coleman JA; Dalbagni G BJU Int; 2013 Apr; 111(4):589-95. PubMed ID: 22642265 [TBL] [Abstract][Full Text] [Related]
19. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249 [TBL] [Abstract][Full Text] [Related]
20. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]